The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Safonova T.N.

FGBU "NII glaznykh bolezneĭ" RAMN, Moskva

Kintukhina N.P.

Research Institute of Eye Diseases, 11 A, B, Rossolimo St., Moscow, Russian Federation, 119021

Effectiveness of a nonsteroidal anti-inflammatory drug in the treatment of chronic non-infectious blepharitis

Authors:

Safonova T.N., Kintukhina N.P.

More about the authors

Journal: Russian Annals of Ophthalmology. 2019;135(6): 73‑82

Read: 3625 times


To cite this article:

Safonova TN, Kintukhina NP. Effectiveness of a nonsteroidal anti-inflammatory drug in the treatment of chronic non-infectious blepharitis. Russian Annals of Ophthalmology. 2019;135(6):73‑82. (In Russ.)
https://doi.org/10.17116/oftalma201913506173

Recommended articles:

References:

  1. Safonova TN, Kintyukhina NP. Involutionary blepharitis: a modern approach to diagnostics and treatment. Vestnik oftal’mologii. 2018;134(1):43-47. (In Russ.) https://doi.org/10.17116/oftalma2018134143-47
  2. Shokirova MM, Kopayeva VG. Evaluation of pathogenetic component of lacrimal substitutive therapy in the complex stage-by-stage treatment of posterior blepharitis, associated with demodectic lesions of the eyelid margins. Oftal’mokhirurgiya. 2017;1:78-82. (In Russ.) https://doi.org/10.25276/0235-4160-2017-1-78-82
  3. Kilic Muftuoglu I, Aydin Akova Y. Clinical Findings, Follow-up and Treatment Results in Patients with Ocular Rosacea. Turkish journal of ophthalmology. 2016;46(1):1-6. https://doi.org/10.4274/tjo.48902
  4. Bezza Benkaouha I, Le Brun C, Pisella PJ, Chandenier J, Lanotte P. Bacterial flora in blepharitis. Journal Francais D’ophtalmologie. 2015;38(8):723-728. https://doi.org/10.1016/j.jfo.2015.01.012
  5. Safonova TN, Kintyukhina NP, Petrenko AE, Gladkova OV. Prevention of dry eye syndrome in chronic demodex blepharitis. RMZh. Klinicheskaya oftal’mologiya. 2016;16(2):89-93. (In Russ.) https://doi.org/10.21689/2311-7729-2016-16-2-89-93
  6. Flach AJ. Cyclo-oxygenase inhibitors in ophthalmology. Surv Ophthalmol. 1992;36(4):259-284. https://doi.org/10.1016/0039-6257(92)90095-b
  7. Flach AJ. Topical nonsteroidal antiinflammatory drugs in ophthalmology. Int Ophthalmol Clin. 2002;42(1):1-11. https://doi.org/10.1097/00004397-200201000-00003
  8. Gaynes BI, Fiscella R. Topical nonsteroidal anti-inflammatory drugs for ophthalmic use: a safety review. Drug Saf. 2002;25(4):233-250. https://doi.org/10.2165/00002018-200225040-00002
  9. Schalnus R. Topical nonsteroidal anti-inflammatory therapy in ophthalmology. Ophthalmologica. 2003;217(2):89-98. https://doi.org/10.1159/000068563
  10. Leonardi A, Busato F, Fregona I, Plebani M, Secchi AG. Anti-inflammatory and antiallergic effects of ketorolac tromethamine in the conjunctival provocation model. The British Journal of Ophthalmology. 2000;84(11):1228-1232. https://doi.org/10.1136/bjo.84.11.1228
  11. Perianin A, Roch-Arveiller M, Giroud JP, Hakim J. In vivo effects of indomethacin and flurbiprofen on the locomotion of neutrophils elicited by immune and non-immune inflammation in the rat. Eur J Pharmacol. 1984;106(2):327-333. https://doi.org/10.1016/0014-2999(84)90720-9
  12. Heier JS, Topping TM, Baumann W, Dirks MS, Chern S. Ketorolac versus prednisolone versus combination therapy in the treatment of acute pseudophakic cystoid macular edema. Ophthalmology. 2000;107(11):2034-2038; discussion 2039. https://doi.org/10.1016/s0161-6420(00)00365-1
  13. O’Brien TP. Emerging guidelines for use of NSAID therapy to optimize cataract surgery patient care. Curr Med Res Opin. 2005;21(7):1131-1137. https://doi.org/10.1185/030079905X50651
  14. Safonova TN, Kintyukhina NP, Petrenko AE, Gladkova OV. First experience of «Deksodem phyto» use in treating chronic demodex blepharitis. Tochka zrenija. Vostok—Zapad. 2016;1:145-147. (In Russ.)
  15. Trubilin VN, Polunina EG, Markova EYu, Kurenkov VV, Kapkova SG. Therapeutic eyelids hygiene in the algorithms of prevention and treatment of ocular surface diseases. Oftal’mologiya. 2016;13(2):122-127. (In Russ.) https://doi.org/10.18008/1816-5095-2016-2-122-127
  16. Kintyukhina NP, Safonova TN, Gladkova OV. The use of laser scanning confocal microscopy of eyelids during intraprototic probing of meibomian glands. Sovremennye tekhnologii v oftal’mologii. 2017;4:112-114. (In Russ.)
  17. Safonova TN, Kintyukhina NP,. Sidorov VV, Gladkova OV. Laser doppler flowmetry in assessing the effectiveness of treatment of chronic demodex blepharitis. Rossiiskii oftal’mologicheskii zhurnal. 2017;10(2):62-66. (In Russ.)
  18. Safonova TN, Kintyukhina NP, Sidorov VV, Gladkova OV, Reyn ES. Microcirculatory blood and lymph flow examination in eyelid skin by laser Doppler flowmetry. Vestnik oftal’mologii. 2017;133(3):16-21. (In Russ.) https://doi.org/10.17116/oftalma2017133316-21
  19. Serebrennikova SN, Seminskii IZh. The role of cytokines in the inflammatory process (Part 1). Sibirskii meditsinskii zhurnal (Irkutsk). 2008;81(6):5-8. (In Russ.)
  20. Lekhanont K, Park CY, Smith JA, Combs JC, Preechawat P, Suwan-Apichon O, Rangsin R, Chuck RS. Effects of topical anti-inflammatory agents in a botulinum toxin B-induced mouse model of keratoconjunctivitis sicca. Journal of ocular pharmacology and therapeutics: the official journal of the Association for Ocular Pharmacology and Therapeutics. 2007;23(1):27-34. https://doi.org/10.1089/jop.2006.0071
  21. el-Harazi SM, Ruiz RS, Feldman RM, Villanueva G, Chuang AZ. A randomized double-masked trial comparing ketorolac tromethamine 0.5%, diclofenac sodium 0.1%, and prednisolone acetate 1% in reducing post-phacoemulsification flare and cells. Ophthalmic Surg Lasers. 1998;29(7):539-544.
  22. Roberts CW, Brennan KM. A comparison of topical diclofenac with prednisolone for postcataract inflammation. Archives of Ophthalmology. 1995;113(6):725-727. https://doi.org/10.1001/archopht.1995.01100060051031
  23. Donnenfeld ED, Holland EJ, Stewart RH, Gow JA, Grillone LR. Bromfenac ophthalmic solution 0.09% (Xibrom) for postoperative ocular pain and inflammation. Ophthalmology. 2007;114(9):1653-1662.
  24. Shimomura Y, Higaki S. The kinetics of herpes virus on the ocular surface and suppression of its reactivation. Cornea. 2011;30(suppl 1):3-7. https://doi.org/10.1097/ICO.0b013e3182282005
  25. Aleksandrova OI, Okolov IN, Khorol’skaya YuI, Panova IE, Blinova MI. Influence of non-steroidal anti-inflammatory eye drops on the epithelium cells of the cornea and conjunctiva in vitro. Oftal’mologiya. 2017;15(3):251-259. (In Russ.) https://doi.org/10.18008/1816-5095-2017-3-251-259
  26. Brzheskii VV, Egorova GB, Egorov EA. Dry eye syndrome and ocular surface disease. Clinic, diagnosis, treatment. M.: GEOTAR-Media; 2016. (In Russ.)
  27. Popov VYu, Brzheskii VV. The effectiveness of 0.09% bromfenac in the treatment of dry eye syndrome of various etiologies. Tochka zreniya. Vostok—Zapad. 2017;1:43-46. (In Russ.)
  28. Safonova TN, Gladkova OV, Novikov IA, Boev VI, Kintyukhina NP. Lechebnaya silikon-gidrogelevaya myagkaya kontaktnaya linza. Patent RF №2612121, priority 27.01.2016. (In Russ.)
  29. Galimova EF, Khaibullina ZG, Enikeev DA, Bortsova YuL, Mochalov KS, Galimova SSh, Travnikov OYu, Asadullina TS, Aver’yanova KS. Effect of bromfenac on free radical oxidation in model systems. Kazanskii meditsinskii zhurnal. 2019;100(4):636-641. (In Russ.) https://doi.org/10.17816/KMJ2019-636
  30. Yanai K, Huang J, Kadonosono K, Uchio E. Corneal sensitivity after topical bromfenac sodium eye-drop instillation. Clinical Ophthalmology. 2013;7:741-744. https://doi.org/10.2147/OPTH.S41801

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.